Does BLINATUMOMAB Cause Infusion site extravasation? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Infusion site extravasation have been filed in association with BLINATUMOMAB (BLINCYTO). This represents 0.1% of all adverse event reports for BLINATUMOMAB.
8
Reports of Infusion site extravasation with BLINATUMOMAB
0.1%
of all BLINATUMOMAB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Infusion site extravasation From BLINATUMOMAB?
Of the 8 reports, 3 (37.5%) required hospitalization.
Is Infusion site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BLINATUMOMAB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does BLINATUMOMAB Cause?
Pyrexia (1,064)
Acute lymphocytic leukaemia recurrent (977)
Cytokine release syndrome (952)
Off label use (590)
Death (588)
Neurotoxicity (530)
Drug ineffective (345)
Headache (335)
Neutropenia (265)
Febrile neutropenia (262)
What Other Drugs Cause Infusion site extravasation?
HUMAN IMMUNOGLOBULIN G (822)
INFLIXIMAB (435)
INFLIXIMAB-DYYB (328)
TREPROSTINIL (256)
VEDOLIZUMAB (199)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (185)
REMDESIVIR (144)
FERRIC CARBOXYMALTOSE (118)
RITUXIMAB (82)
NATALIZUMAB (70)
Which BLINATUMOMAB Alternatives Have Lower Infusion site extravasation Risk?
BLINATUMOMAB vs BLONANSERIN
BLINATUMOMAB vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1
BLINATUMOMAB vs BOCEPREVIR
BLINATUMOMAB vs BOCOCIZUMAB
BLINATUMOMAB vs BONIVA